{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:09:11Z","timestamp":1777280951656,"version":"3.51.4"},"reference-count":29,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to severe complications, such as stroke and seizure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the neurological findings and to determine etiological risk factors for mortality in patients hospitalized for COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records of patients with COVID-19 who were hospitalized and sought neurological consultation between March 2020 and March 2021 at a reference pandemic hospital in Turkey were reviewed retrospectively in a cross-sectional study design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>We included data from 150 (94 male) patients. Their mean age \u00b1 standard deviation was 68.56 \u00b1 16.02 (range 21\u201397) years. The patients were categorized into 2 groups according to any acute neurological event or progression of neurological disease. Ischemic cerebrovascular events, seizures, and encephalopathy were the most common acute neurological events, while deterioration in consciousness, epileptic seizures, and Parkinson disease were observed in those with progression of neurological disease. Abnormal neurological findings were found at a mean of 7.8 \u00b1 9.7 days following COVID-19 diagnosis and 50 (a third of) patients died. A logistic regression model found that advanced age, increased Modified Charlson Comorbidity Index (MCCI) score, and prolonged duration of hospitalization were factors significantly associated with increased mortality; however, sex and day of abnormal neurological findings after COVID-19 diagnosis were not. Common conditions accompanying neurological events were hypertension, coronary artery disease\u2013heart failure, and diabetes mellitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>COVID-19 may present with neurological symptoms in our Turkish patients and comorbidities are often present.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/abm-2022-0004","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T05:46:22Z","timestamp":1647236782000},"page":"23-30","source":"Crossref","is-referenced-by-count":3,"title":["Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey"],"prefix":"10.2478","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-1194","authenticated-orcid":false,"given":"Nuray Can","family":"Usta","sequence":"first","affiliation":[{"name":"Department of Neurology , University of Health Science , Trabzon Kanuni Training and Research Hospital , Trabzon , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6406-4669","authenticated-orcid":false,"given":"Seyfi","family":"Kartal","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Reanimation , University of Health Science , Trabzon Kanuni Training and Research Hospital , Trabzon , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5465-2635","authenticated-orcid":false,"given":"Betul Onal","family":"Gunay","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology , University of Health Science , Trabzon Kanuni Training and Research Hospital , Trabzon , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-3304","authenticated-orcid":false,"given":"Cavit","family":"Boz","sequence":"additional","affiliation":[{"name":"Department of Neurology , Karadeniz Technical University , School of Medicine , Trabzon , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"2026042708181935772_j_abm-2022-0004_ref_001","doi-asserted-by":"crossref","unstructured":"Manji H, Carr AS, Brownlee WJ, Lunn MP. Neurology in the time of COVID-19. J Neurol Neurosurg Psychiatry. 2020; 91:568\u201370.","DOI":"10.1136\/jnnp-2020-323414"},{"key":"2026042708181935772_j_abm-2022-0004_ref_002","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061\u20139.","DOI":"10.1001\/jama.2020.1585"},{"key":"2026042708181935772_j_abm-2022-0004_ref_003","doi-asserted-by":"crossref","unstructured":"Liu Y, Xia P, Cao W, Liu Z, Ma J, Zheng K, et al. Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients. Ren Fail. 2021; 43:1104\u201314.","DOI":"10.1080\/0886022X.2021.1948428"},{"key":"2026042708181935772_j_abm-2022-0004_ref_004","doi-asserted-by":"crossref","unstructured":"Han H, Xie L, Liu R, Yang J, Liu F, Wu K, Chen L, et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol. 2020; 92:819\u201323.","DOI":"10.1002\/jmv.25809"},{"key":"2026042708181935772_j_abm-2022-0004_ref_005","doi-asserted-by":"crossref","unstructured":"Han H, Yang L, Liu R, Liu F, Wu K-l, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020; 58:1116\u201320.","DOI":"10.1515\/cclm-2020-0188"},{"key":"2026042708181935772_j_abm-2022-0004_ref_006","doi-asserted-by":"crossref","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77:683\u201390.","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"2026042708181935772_j_abm-2022-0004_ref_007","doi-asserted-by":"crossref","unstructured":"Karada\u015f \u00d6, \u00d6zt\u00fcrk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020; 41:1991\u20135.","DOI":"10.1007\/s10072-020-04547-7"},{"key":"2026042708181935772_j_abm-2022-0004_ref_008","doi-asserted-by":"crossref","unstructured":"Esp\u00edndola OM, Brand\u00e3o CO, Gomes YCP, Siqueira M, Soares CN, Lima MASD, et al. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Int J Infect Dis. 2021; 102:155\u201362.","DOI":"10.1016\/j.ijid.2020.10.044"},{"key":"2026042708181935772_j_abm-2022-0004_ref_009","doi-asserted-by":"crossref","unstructured":"Li YC, Bai W-Z, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92:552\u20135.","DOI":"10.1002\/jmv.25728"},{"key":"2026042708181935772_j_abm-2022-0004_ref_010","doi-asserted-by":"crossref","unstructured":"Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020; 142:14\u201322.","DOI":"10.1111\/ane.13266"},{"key":"2026042708181935772_j_abm-2022-0004_ref_011","doi-asserted-by":"crossref","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020; 11:995\u20138.","DOI":"10.1021\/acschemneuro.0c00122"},{"key":"2026042708181935772_j_abm-2022-0004_ref_012","doi-asserted-by":"crossref","unstructured":"Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020; 72:1059\u201363.","DOI":"10.1002\/art.41285"},{"key":"2026042708181935772_j_abm-2022-0004_ref_013","doi-asserted-by":"crossref","unstructured":"Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021; 33:155\u201362.","DOI":"10.1097\/BOR.0000000000000776"},{"key":"2026042708181935772_j_abm-2022-0004_ref_014","doi-asserted-by":"crossref","unstructured":"Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. 2020; 40:1539\u201354.","DOI":"10.1007\/s00296-020-04639-9"},{"key":"2026042708181935772_j_abm-2022-0004_ref_015","doi-asserted-by":"crossref","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147:573\u20137.","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"2026042708181935772_j_abm-2022-0004_ref_016","doi-asserted-by":"crossref","unstructured":"Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al.; RECORD Working Committee. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015; 12:e1001885. doi: 10.1371\/journal.pmed.1001885","DOI":"10.1371\/journal.pmed.1001885"},{"key":"2026042708181935772_j_abm-2022-0004_ref_017","doi-asserted-by":"crossref","unstructured":"Bolay H, G\u00fcl A, Baykan B. COVID-19 is a real headache! Headache. 2020; 60:1415\u201321.","DOI":"10.1111\/head.13856"},{"key":"2026042708181935772_j_abm-2022-0004_ref_018","doi-asserted-by":"crossref","unstructured":"Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2021; 51:1107\u201310.","DOI":"10.1007\/s11239-020-02105-8"},{"key":"2026042708181935772_j_abm-2022-0004_ref_019","doi-asserted-by":"crossref","unstructured":"Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS-CoV-2 and stroke in a New York Healthcare system. Stroke. 2020; 51:2002\u201311.","DOI":"10.1161\/STROKEAHA.120.030335"},{"key":"2026042708181935772_j_abm-2022-0004_ref_020","doi-asserted-by":"crossref","unstructured":"Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020; 417:117085. doi: 10.1016\/j.jns.2020.117085","DOI":"10.1016\/j.jns.2020.117085"},{"key":"2026042708181935772_j_abm-2022-0004_ref_021","doi-asserted-by":"crossref","unstructured":"Morelli N, Rota E, Terracciano C, Immovilli P, Spallazzi M, Colombi D, et al. The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 era. Eur Neurol. 2020; 83:213\u20135.","DOI":"10.1159\/000507666"},{"key":"2026042708181935772_j_abm-2022-0004_ref_022","doi-asserted-by":"crossref","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18:1094\u20139.","DOI":"10.1111\/jth.14817"},{"key":"2026042708181935772_j_abm-2022-0004_ref_023","doi-asserted-by":"crossref","unstructured":"Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study. Epilepsia. 2020; 61:e49\u201353. doi: 10.1111\/epi.16524","DOI":"10.1111\/epi.16524"},{"key":"2026042708181935772_j_abm-2022-0004_ref_024","doi-asserted-by":"crossref","unstructured":"Somani S, Pati S, Gaston T, Chitlangia A, Agnihotri S. De novo status epilepticus in patients with COVID-19. Ann Clin Transl Neurol. 2020; 7:1240\u20134.","DOI":"10.1002\/acn3.51071"},{"key":"2026042708181935772_j_abm-2022-0004_ref_025","doi-asserted-by":"crossref","unstructured":"Balloy G, Leclair-Visonneau L, P\u00e9r\u00e9on Y, Magot A, Peyre A, Mah\u00e9 P-J, Derkinderen P. Non-lesional status epilepticus in a patient with coronavirus disease 2019. Clin Neurophysiol. 2020; 131:2059\u201361.","DOI":"10.1016\/j.clinph.2020.05.005"},{"key":"2026042708181935772_j_abm-2022-0004_ref_026","doi-asserted-by":"crossref","unstructured":"Lyons S, O\u2019Kelly B, Woods S, Rowan C, Brady D, Sheehan G, Smyth S. Seizure with CSF lymphocytosis as a presenting feature of COVID-19 in an otherwise healthy young man. Seizure. 2020; 80:113\u20134.","DOI":"10.1016\/j.seizure.2020.06.010"},{"key":"2026042708181935772_j_abm-2022-0004_ref_027","doi-asserted-by":"crossref","unstructured":"Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Res Social Adm Pharm. 2021; 17:1978\u201383.","DOI":"10.1016\/j.sapharm.2020.04.001"},{"key":"2026042708181935772_j_abm-2022-0004_ref_028","doi-asserted-by":"crossref","unstructured":"Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020; 19:383\u20134.","DOI":"10.1016\/S1474-4422(20)30109-5"},{"key":"2026042708181935772_j_abm-2022-0004_ref_029","doi-asserted-by":"crossref","unstructured":"Matta S, Chopra KK, Arora VK. Morbidity and mortality trends of Covid 19 in top 10 countries. Indian J Tuberc. 2020; 67(4S):S167\u201372.","DOI":"10.1016\/j.ijtb.2020.09.031"}],"container-title":["Asian Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/abm-2022-0004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:18:39Z","timestamp":1777277919000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/abm-2022-0004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2,28]]},"published-print":{"date-parts":[[2022,2,1]]}},"alternative-id":["10.2478\/abm-2022-0004"],"URL":"https:\/\/doi.org\/10.2478\/abm-2022-0004","relation":{},"ISSN":["1875-855X"],"issn-type":[{"value":"1875-855X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}